Corient Private Wealth LLC Has $1.47 Million Position in Encompass Health Co. (NYSE:EHC)

Corient Private Wealth LLC trimmed its position in shares of Encompass Health Co. (NYSE:EHC) by 21.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 15,963 shares of the company’s stock after selling 4,270 shares during the period. Corient Private Wealth LLC’s holdings in Encompass Health were worth $1,474,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently bought and sold shares of the company. MassMutual Private Wealth & Trust FSB raised its stake in shares of Encompass Health by 87.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock worth $27,000 after purchasing an additional 137 shares in the last quarter. Avior Wealth Management LLC bought a new position in Encompass Health during the third quarter valued at approximately $40,000. CBIZ Investment Advisory Services LLC grew its position in Encompass Health by 38.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company’s stock worth $42,000 after acquiring an additional 127 shares in the last quarter. Tompkins Financial Corp acquired a new position in shares of Encompass Health during the 4th quarter worth $46,000. Finally, V Square Quantitative Management LLC raised its holdings in shares of Encompass Health by 43.8% during the 4th quarter. V Square Quantitative Management LLC now owns 581 shares of the company’s stock valued at $54,000 after purchasing an additional 177 shares in the last quarter. Institutional investors and hedge funds own 97.25% of the company’s stock.

Encompass Health Stock Up 0.8 %

Shares of EHC opened at $100.71 on Wednesday. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05. The company has a 50-day simple moving average of $98.28 and a 200-day simple moving average of $97.26. Encompass Health Co. has a 52 week low of $76.11 and a 52 week high of $104.55. The firm has a market capitalization of $10.14 billion, a P/E ratio of 22.58, a P/E/G ratio of 2.31 and a beta of 0.92.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Thursday, February 6th. The company reported $1.17 EPS for the quarter, topping analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. On average, equities research analysts expect that Encompass Health Co. will post 4.8 earnings per share for the current year.

Encompass Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be paid a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.68%. The ex-dividend date of this dividend is Tuesday, April 1st. Encompass Health’s dividend payout ratio is 15.25%.

Analyst Ratings Changes

EHC has been the topic of several analyst reports. Royal Bank of Canada reissued an “outperform” rating and set a $110.00 target price on shares of Encompass Health in a research report on Tuesday, February 11th. Barclays raised their price objective on Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday, February 7th. KeyCorp upped their target price on Encompass Health from $117.00 to $120.00 and gave the stock an “overweight” rating in a research report on Monday, February 10th. StockNews.com raised shares of Encompass Health from a “hold” rating to a “buy” rating in a research report on Saturday, February 15th. Finally, William Blair reiterated an “outperform” rating on shares of Encompass Health in a research note on Friday, February 7th. Ten equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, Encompass Health currently has an average rating of “Buy” and an average price target of $107.67.

Insider Transactions at Encompass Health

In related news, CAO Andrew L. Price sold 5,042 shares of the stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $98.29, for a total value of $495,578.18. Following the completion of the transaction, the chief accounting officer now owns 69,164 shares of the company’s stock, valued at $6,798,129.56. This represents a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 2.10% of the stock is owned by insiders.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.